IL161500A0 - Taste masking spill-resistant formulation - Google Patents
Taste masking spill-resistant formulationInfo
- Publication number
- IL161500A0 IL161500A0 IL16150002A IL16150002A IL161500A0 IL 161500 A0 IL161500 A0 IL 161500A0 IL 16150002 A IL16150002 A IL 16150002A IL 16150002 A IL16150002 A IL 16150002A IL 161500 A0 IL161500 A0 IL 161500A0
- Authority
- IL
- Israel
- Prior art keywords
- taste masking
- resistant formulation
- spill
- base
- pharmaceutical agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33044701P | 2001-10-22 | 2001-10-22 | |
| PCT/US2002/033478 WO2003034991A2 (en) | 2001-10-22 | 2002-10-22 | Taste masking spill-resistant formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161500A0 true IL161500A0 (en) | 2004-09-27 |
Family
ID=23289820
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16150002A IL161500A0 (en) | 2001-10-22 | 2002-10-22 | Taste masking spill-resistant formulation |
| IL161500A IL161500A (en) | 2001-10-22 | 2004-04-19 | Taste masking spill-resistant formulation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL161500A IL161500A (en) | 2001-10-22 | 2004-04-19 | Taste masking spill-resistant formulation |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1438026B1 (xx) |
| JP (3) | JP2005506993A (xx) |
| KR (1) | KR20040084891A (xx) |
| CN (1) | CN1571661A (xx) |
| AT (1) | ATE505183T1 (xx) |
| AU (1) | AU2002356831B2 (xx) |
| BR (1) | BR0213379A (xx) |
| CA (2) | CA2466036C (xx) |
| DE (1) | DE60239752D1 (xx) |
| IL (2) | IL161500A0 (xx) |
| MX (1) | MXPA04003789A (xx) |
| WO (1) | WO2003034991A2 (xx) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5398100B2 (ja) * | 2003-06-23 | 2014-01-29 | 大正製薬株式会社 | 鉄化合物を含む内服液剤組成物 |
| US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
| GB2430364A (en) * | 2005-09-22 | 2007-03-28 | Carl Ernest Alexander | Soft agar bolus for oral drug delivery |
| KR101351674B1 (ko) * | 2005-09-30 | 2014-01-14 | 디에스엠 아이피 어셋츠 비.브이. | 폴리페놀을 함유하는 신규 조성물 |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| EP2029132A4 (en) * | 2006-01-25 | 2011-07-27 | Taro Pharmaceuticals North America Inc | ANTIHISTAMINE COMPOSITIONS AND THEIR USE |
| WO2010010568A1 (en) * | 2008-07-22 | 2010-01-28 | Lupin Limited | Oral compositions of clindamycin |
| WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| AU2010300641B2 (en) | 2009-09-30 | 2016-03-17 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
| FR2987268B1 (fr) | 2012-02-28 | 2014-07-11 | Ammtek | Formulations liquides de sulfamides hypoglycemiants |
| WO2014085599A1 (en) | 2012-11-30 | 2014-06-05 | Acura Pharmaceuticals, Inc. | Self-regulated release of active pharmaceutical ingredient |
| CA2906389A1 (en) * | 2013-03-15 | 2014-09-25 | Novartis Consumer Health Inc. | Dye free liquid therapeutic solution |
| CA2919892C (en) | 2013-08-12 | 2019-06-18 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| EP3169315B1 (en) | 2014-07-17 | 2020-06-24 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
| AU2015336065A1 (en) | 2014-10-20 | 2017-05-04 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
| US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
| CA3045118A1 (en) | 2016-11-28 | 2018-05-31 | Johnson & Johnson Consumer Inc. | Liquid compositions comprising a mucoadhesive agent |
| NL2024161B1 (en) * | 2019-11-05 | 2021-07-20 | Mperium B V | Pharmaceutical liquid composition, kit of parts comprising the pharmaceutical liquid composition, and method for preparing the pharmaceutical liquid composition |
| CN112274483A (zh) * | 2020-10-28 | 2021-01-29 | 河北冀衡药业股份有限公司 | 一种对乙酰氨基酚混悬滴剂及其制备方法 |
| EP4368171A1 (en) * | 2022-11-08 | 2024-05-15 | Laboratorios Ern S.A. | Paracetamol oral solution |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4427681A (en) * | 1982-09-16 | 1984-01-24 | Richardson-Vicks, Inc. | Thixotropic compositions easily convertible to pourable liquids |
| US4806354A (en) * | 1984-04-06 | 1989-02-21 | Green James P | Health food composition |
| US5288479A (en) * | 1989-01-17 | 1994-02-22 | Sterling Drug, Inc. | Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof |
| JPH0714872B2 (ja) * | 1990-02-06 | 1995-02-22 | 昭和薬品化工株式会社 | シロップ剤組成物 |
| US5300302A (en) * | 1990-10-04 | 1994-04-05 | Nestec S.A. | Pharmaceutical composition in gel form in a dispensing package |
| IL108366A (en) * | 1993-03-11 | 1999-11-30 | Taro Vit Ind Ltd | Semi-solid pharmaceutical compounds and a device for their use |
| US5563177A (en) * | 1995-01-30 | 1996-10-08 | American Home Products Corporation | Taste masking guaifenesin containing liquids |
| US5616621A (en) * | 1995-01-30 | 1997-04-01 | American Home Products Corporation | Taste masking liquids |
| US5919481A (en) * | 1996-06-28 | 1999-07-06 | Ncneil-Ppc, Inc. | Fill material for soft gelatin pharmaceutical dosage form |
| US6010683A (en) * | 1997-11-05 | 2000-01-04 | Ultradent Products, Inc. | Compositions and methods for reducing the quantity but not the concentration of active ingredients delivered by a dentifrice |
| US6071523A (en) * | 1998-06-03 | 2000-06-06 | Taro Pharmaceuticals Industries, Ltd. | Spill resistant pharmaceutical compositions in semi-solid form |
-
2002
- 2002-10-22 AT AT02802169T patent/ATE505183T1/de not_active IP Right Cessation
- 2002-10-22 CN CNA028208129A patent/CN1571661A/zh active Pending
- 2002-10-22 JP JP2003537560A patent/JP2005506993A/ja not_active Withdrawn
- 2002-10-22 WO PCT/US2002/033478 patent/WO2003034991A2/en active Application Filing
- 2002-10-22 IL IL16150002A patent/IL161500A0/xx unknown
- 2002-10-22 DE DE60239752T patent/DE60239752D1/de not_active Expired - Lifetime
- 2002-10-22 CA CA2466036A patent/CA2466036C/en not_active Expired - Fee Related
- 2002-10-22 KR KR10-2004-7005757A patent/KR20040084891A/ko not_active Application Discontinuation
- 2002-10-22 CA CA2764642A patent/CA2764642A1/en not_active Abandoned
- 2002-10-22 EP EP02802169A patent/EP1438026B1/en not_active Expired - Lifetime
- 2002-10-22 MX MXPA04003789A patent/MXPA04003789A/es not_active Application Discontinuation
- 2002-10-22 BR BR0213379-2A patent/BR0213379A/pt not_active IP Right Cessation
- 2002-10-22 AU AU2002356831A patent/AU2002356831B2/en not_active Ceased
-
2004
- 2004-04-19 IL IL161500A patent/IL161500A/en not_active IP Right Cessation
-
2009
- 2009-01-21 JP JP2009010954A patent/JP5185844B2/ja not_active Expired - Fee Related
-
2012
- 2012-10-22 JP JP2012232683A patent/JP2013014626A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040084891A (ko) | 2004-10-06 |
| WO2003034991A2 (en) | 2003-05-01 |
| AU2002356831B2 (en) | 2006-06-08 |
| CA2466036A1 (en) | 2003-05-01 |
| ATE505183T1 (de) | 2011-04-15 |
| CA2764642A1 (en) | 2003-05-01 |
| JP2005506993A (ja) | 2005-03-10 |
| EP1438026A2 (en) | 2004-07-21 |
| EP1438026B1 (en) | 2011-04-13 |
| CN1571661A (zh) | 2005-01-26 |
| WO2003034991A3 (en) | 2004-02-26 |
| CA2466036C (en) | 2012-04-24 |
| MXPA04003789A (es) | 2005-06-03 |
| IL161500A (en) | 2012-10-31 |
| JP2013014626A (ja) | 2013-01-24 |
| JP2009102389A (ja) | 2009-05-14 |
| JP5185844B2 (ja) | 2013-04-17 |
| DE60239752D1 (de) | 2011-05-26 |
| BR0213379A (pt) | 2005-02-01 |
| EP1438026A4 (en) | 2005-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL161500A0 (en) | Taste masking spill-resistant formulation | |
| WO2002080976A3 (en) | Hsa-free formulations of interferon-beta | |
| HK1080364A1 (en) | Oral pharmaceutical forms of liquid drugs having improved bioavailability | |
| WO2003045331A3 (en) | Formulations for oral administration of cromolyn sodium | |
| EP1246608A4 (en) | PHARMACEUTICAL PREPARATIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES WITH LOW WATER SOLUBILITY | |
| HUP0300207A3 (en) | 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes | |
| CA2189328A1 (en) | Tocopherol compositions for delivery of biologically active agents | |
| HUP0203168A2 (hu) | Készítmények nyálkahártyán át történő beadásra | |
| MY129406A (en) | Taste masked liquid pharmaceutical compositions | |
| WO2005065646A3 (en) | Novel drug compositions and dosage forms | |
| DE69942154D1 (de) | Medikamenthaltige zusammensetzung in aerosolform | |
| AU3085102A (en) | Drug delivery compositions and medical devices containing block copolymer | |
| EE05089B1 (et) | Amiidasendatud imidasokinoliinid ja neid sisaldavad farmatseutilised preparaadid | |
| MY129350A (en) | Aripiprazole oral solution | |
| MY111177A (en) | Flavour-masked pharmaceutical compositions | |
| HUP0104934A3 (en) | Peptide analogues of pacap, pharmaceutical compositions comprising thereof and their use | |
| HUP0401174A3 (en) | Ecteinascidin analogues, their use in the preparation of a medicament for treatment of cancer and pharmaceutical compositions containing the compounds | |
| HUP0400246A3 (en) | 1,2,4-trioxolane antimalarial pharmaceutical compositions and process for their preparation and use | |
| WO2000021510A3 (en) | Formulations of fexofenadine | |
| WO2000050046A8 (en) | Stabilized oral pharmaceutical composition containing iodide and iodate and method | |
| ATE287264T1 (de) | Oral anzuwendende buprenorphinhaltige arzneimittel | |
| ATE230258T1 (de) | Injizierbares arzneimittel auf basis eines pharmazeutisch verträglichen salzes von clopidogrel bzw. von ticlopidin | |
| WO2002015892A3 (en) | Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors | |
| SE0001916D0 (sv) | Novel formulation | |
| EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration |